Chase AIPricingFAQs
Display currency
Loading news…

Vaxcell Bio Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Hwasun, Cholla-namdo, South Korea Founded 2010 11-50 employees For Profit

Vaxcell Bio Therapeutics is an pharmaceutical firm that develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Ticker
323990
KRX

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
323990
Exchange
KRX
IPO date
Sep 22, 2020

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2

Company Info

Founded
2010
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
HQ
Hwasun, Cholla-namdo, South Korea
Region
Asia-Pacific (APAC)
Exit date
Sep 22, 2020

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.7
Trend (90d)
0

Key People at Vaxcell Bio Therapeutics

Founder and CSO
Founder and CEO

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Vaxcell Bio Therapeutics

Loading news…

FAQs about Vaxcell Bio Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Vaxcell Bio Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments